Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL17201525

Cc1ncc(-c2cnc(C(=O)O)s2)cn1.O=C(O)C(F)(F)F

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 6/20 0.37
HDAC4 P56524 1/20 0.37
HSD17B1 P14061 2/20 0.36
HSD17B2 P37059 2/20 0.36
CSNK2A1 P68400 1/20 0.35
HCAR2 Q8TDS4 1/20 0.34
HDAC1 Q13547 5/20 0.33
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
GAA P10253 2/20 0.33
NPC1 O15118 1/20 0.33
GLA P06280 1/20 0.33
POLB P06746 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CDC7 O00311 1/20 0.33
DBF4 Q9UBU7 1/20 0.33
ESR1 P03372 1/20 0.32
CTSS P25774 1/20 0.32
CTSK P43235 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17201499 0.91 CSNK2A1 (0.40) HDAC6HSD17B1HSD17B2CSNK2A1HCAR2
Trifluoroacetic Acid SCHEMBL17201556 0.85 HDAC6 (0.37) HDAC6HDAC4HSD17B1HSD17B2CSNK2A1
Trifluoroacetic Acid SCHEMBL17201554 0.79 CTSS (0.36) HDAC6HDAC4HSD17B1HSD17B2CSNK2A1
SCHEMBL17201526 0.78 HSD17B1 (0.34) HDAC6HDAC4HSD17B1HSD17B2ALDH1A1
Trifluoroacetic Acid SCHEMBL17201543 0.76 SORT1 (0.37) KDM4EGAAGLARAB9ACDC7
Trifluoroacetic Acid SCHEMBL17201599 0.76 CTSS (0.39) HDAC6HDAC4HSD17B1HSD17B2HCAR2
Trifluoroacetic Acid SCHEMBL17204972 0.75 KDM4E (0.39) HDAC6HDAC4HCAR2HDAC1KDM4E
Trifluoroacetic Acid SCHEMBL17201540 0.74 CDC7 (0.44) HDAC6HDAC4HSD17B1HSD17B2POLB
Trifluoroacetic Acid SCHEMBL17201561 0.74 KDM4E (0.54) HDAC6HDAC4HDAC1KDM4EALDH1A1
SCHEMBL17201608 0.73 ALDH1A1 (0.37) HSD17B1HSD17B2ALDH1A1CTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9725459-B2 3-oxo-tetrahydro-furo[3,2-B]pyrrol-4(5H)-yl) derivatives I GRUNENTHAL GMBH (DE) 2017-08-08 US disclosed
EP-3140309-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I Grünenthal GmbH (DE) 2017-03-15 EP disclosed
EP-3134414-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES II Grünenthal GmbH (DE) 2017-03-01 EP disclosed
WO-2015161924-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES II Grünenthal GmbH (DE) 2015-10-29 WO disclosed
WO-2015161928-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I Grünenthal GmbH (DE) 2015-10-29 WO disclosed
US-20150307507-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I Grünenthal GmbH (DE) 2015-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150307507-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I CTSK, OPRK1, CAT HDAC6 533/4885HDAC4 1433/4885HSD17B1 3237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.